PPARalpha_NN
activators_NNS
inhibit_VBP
cytokine-induced_JJ
vascular_JJ
cell_NN
adhesion_NN
molecule-1_NN
expression_NN
in_IN
human_JJ
endothelial_JJ
cells_NNS
._.

BACKGROUND_NN
:_:
Adhesion_NN
molecule_NN
expression_NN
on_IN
the_DT
endothelial_JJ
cell_NN
-LRB-_-LRB-
EC_NN
-RRB-_-RRB-
surface_NN
is_VBZ
critical_JJ
for_IN
leukocyte_NN
recruitment_NN
to_TO
atherosclerotic_JJ
lesions_NNS
._.

Better_JJR
understanding_NN
of_IN
transcriptional_JJ
regulation_NN
of_IN
adhesion_NN
molecules_NNS
in_IN
ECs_NNS
may_MD
provide_VB
important_JJ
insight_NN
into_IN
plaque_NN
formation_NN
._.

Peroxisome_NN
proliferator-activated_JJ
receptor-alpha_NN
-LRB-_-LRB-
PPARalpha_NN
-RRB-_-RRB-
,_,
a_DT
member_NN
of_IN
the_DT
nuclear_JJ
receptor_NN
family_NN
,_,
regulates_VBZ
gene_NN
expression_NN
in_IN
response_NN
to_TO
certain_JJ
fatty_JJ
acids_NNS
and_CC
fibric_JJ
acid_NN
derivatives_NNS
._.

The_DT
present_JJ
study_NN
investigated_VBD
PPARalpha_NN
expression_NN
in_IN
human_JJ
ECs_NNS
and_CC
their_PRP$
regulation_NN
of_IN
vascular_JJ
cell_NN
adhesion_NN
molecule-1_NN
-LRB-_-LRB-
VCAM-1_NN
-RRB-_-RRB-
._.

METHODS_NNS
AND_CC
RESULTS_NNS
:_:
Immunohistochemistry_NN
revealed_VBD
that_IN
human_JJ
carotid_NN
artery_NN
ECs_NNS
express_VBP
PPARalpha_NN
._.

Pretreatment_NN
of_IN
cultured_VBN
human_JJ
ECs_NNS
with_IN
the_DT
PPARalpha_NN
activators_NNS
fenofibrate_NN
or_CC
WY14643_NN
inhibited_VBD
TNF-alpha-induced_JJ
VCAM-1_NN
in_IN
a_DT
time_NN
-_:
and_CC
concentration-dependent_JJ
manner_NN
,_,
an_DT
effect_NN
not_RB
seen_VBN
with_IN
PPARgamma_NN
activators_NNS
._.

Both_DT
PPARalpha_NN
activators_NNS
decreased_VBD
cytokine-induced_JJ
VCAM-1_NN
mRNA_NN
expression_NN
without_IN
altering_VBG
its_PRP$
mRNA_NN
half-life_NN
._.

Transient_JJ
transfection_NN
of_IN
deletional_JJ
VCAM-1_NN
promoter_NN
constructs_NNS
and_CC
electrophoretic_JJ
mobility_NN
shift_NN
assays_NNS
suggest_VBP
that_IN
fenofibrate_NN
inhibits_VBZ
VCAM-1_NN
transcription_NN
in_IN
part_NN
by_IN
inhibiting_VBG
NF-kappaB_NN
._.

Finally_RB
,_,
PPARalpha_NN
activators_NNS
significantly_RB
reduced_VBD
adhesion_NN
of_IN
U937_NN
cells_NNS
to_TO
cultured_VBN
human_JJ
ECs_NNS
._.

CONCLUSIONS_NNS
:_:
Human_JJ
ECs_NNS
express_VBP
PPARalpha_NN
,_,
a_DT
potentially_RB
important_JJ
regulator_NN
of_IN
atherogenesis_NN
through_IN
its_PRP$
transcriptional_JJ
control_NN
of_IN
VCAM-1_NN
gene_NN
expression_NN
._.

Such_JJ
findings_NNS
also_RB
have_VBP
implications_NNS
regarding_VBG
the_DT
clinical_JJ
use_NN
of_IN
lipid-lowering_JJ
agents_NNS
,_,
like_IN
fibric_JJ
acids_NNS
,_,
which_WDT
can_MD
activate_VB
PPARalpha_NN
._.

